Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

A patient's grey hair regained color during treatment with adalimumab.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Dupilumab effectively treated severe alopecia areata in a child.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

The drug combination was safe and showed promise in treating advanced tumors.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Anifrolumab helped a woman with severe lupus achieve remission when other treatments failed.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Cetuximab can cause unusual hair growth and hair loss.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Tofacitinib helped a woman regrow hair with no major side effects.